The UK Precision Medicine Catapult
Key to the Precision Medicine Catapult's aim is the ability to capitalise on the UK's high quality precision medicine infrastructure and regional expertise, so that we can deliver products and services by breaking through the barriers to their translation, adoption and implementation. Our activities will range across clinical trials, device and diagnostic development, regulatory and reimbursement issues, as well as harnessing big data and bioinformatics. We will also be working with a broad range of partners - academics, clinicians, companies, the National Health Service, disease groups and patients. From next generation sequencing to CAR-T therapies, biobanks to patient data records, it is clear that the Precision Medicine Catapult is active in areas in which there is vigorous bioethical debate. In his remarks Precision Medicine Catapult Chairman Professor Barker will address how the organisation will engage in these debates and influence policy, to ensure that the whole of the UK population benefits from the advent of precision medicine.